JP2024513559A5 - - Google Patents
Info
- Publication number
- JP2024513559A5 JP2024513559A5 JP2023561342A JP2023561342A JP2024513559A5 JP 2024513559 A5 JP2024513559 A5 JP 2024513559A5 JP 2023561342 A JP2023561342 A JP 2023561342A JP 2023561342 A JP2023561342 A JP 2023561342A JP 2024513559 A5 JP2024513559 A5 JP 2024513559A5
- Authority
- JP
- Japan
- Prior art keywords
- repeat domain
- ankyrin repeat
- human
- binding
- binding specificity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163173186P | 2021-04-09 | 2021-04-09 | |
| US202163172973P | 2021-04-09 | 2021-04-09 | |
| US63/172,973 | 2021-04-09 | ||
| US63/173,186 | 2021-04-09 | ||
| US202163265181P | 2021-12-09 | 2021-12-09 | |
| US63/265,181 | 2021-12-09 | ||
| PCT/IB2022/053275 WO2022215032A1 (en) | 2021-04-09 | 2022-04-07 | Novel darpin based cd70 engagers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024513559A JP2024513559A (ja) | 2024-03-26 |
| JP2024513559A5 true JP2024513559A5 (https=) | 2025-04-03 |
Family
ID=81386901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023561342A Pending JP2024513559A (ja) | 2021-04-09 | 2022-04-07 | 新規なＤＡＲＰｉｎベースのＣＤ７０エンゲージャー |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250074994A1 (https=) |
| EP (1) | EP4319883A1 (https=) |
| JP (1) | JP2024513559A (https=) |
| KR (1) | KR20230169182A (https=) |
| AU (1) | AU2022252985A1 (https=) |
| BR (1) | BR112023020685A2 (https=) |
| CA (1) | CA3214020A1 (https=) |
| MX (1) | MX2023011978A (https=) |
| WO (1) | WO2022215032A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240279290A1 (en) | 2020-05-14 | 2024-08-22 | Molecular Partners Ag | Multispecific proteins |
| BR112023018293A2 (pt) | 2021-03-09 | 2023-10-31 | Molecular Partners Ag | Acopladores de célula t multiespecíficos à base de darpin |
| EP4724460A1 (en) * | 2023-06-06 | 2026-04-15 | Molecular Partners AG | Recombinant cd16a binding proteins and their use |
| EP4724486A1 (en) | 2023-06-06 | 2026-04-15 | Molecular Partners AG | Recombinant cd2 binding proteins and their use |
| WO2025181039A1 (en) | 2024-03-01 | 2025-09-04 | Molecular Partners Ag | Therapeutic combinations comprising a multi-specific t cell engager |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3974453A3 (en) * | 2010-11-16 | 2022-08-03 | Amgen Inc. | Agents and methods for treating diseases that correlate with bcma expression |
| PL2643349T3 (pl) * | 2010-11-26 | 2020-03-31 | Molecular Partners Ag | Zaprojektowane białka z powtórzeniami wiążące się z albuminą surowicy |
| AU2014317009A1 (en) * | 2013-09-05 | 2016-03-10 | Aduro Biotech Holdings, Europe B.V. | CD70-binding peptides and method, process and use relating thereto |
| KR102427117B1 (ko) * | 2015-04-02 | 2022-07-29 | 몰리큘라 파트너스 아게 | 혈청 알부민에 대한 결합 특이성을 갖는 설계된 안키린 반복 도메인 |
| WO2017165464A1 (en) * | 2016-03-21 | 2017-09-28 | Elstar Therapeutics, Inc. | Multispecific and multifunctional molecules and uses thereof |
| PE20210708A1 (es) * | 2018-02-01 | 2021-04-16 | Pfizer | Anticuerpos especificos para cd70 y sus usos |
| KR20260046525A (ko) * | 2018-04-11 | 2026-04-07 | 인히브릭스 바이오사이언스, 인크. | 제한된 cd3 결합을 갖는 다중특이적 폴리펩티드 컨스트럭트 및 관련된 방법 및 용도 |
| CN114222757A (zh) * | 2019-06-04 | 2022-03-22 | 分子伴侣公司 | 重组4-1bb结合蛋白及其用途 |
| WO2020245746A1 (en) * | 2019-06-04 | 2020-12-10 | Molecular Partners Ag | Multispecific proteins |
-
2022
- 2022-04-07 WO PCT/IB2022/053275 patent/WO2022215032A1/en not_active Ceased
- 2022-04-07 JP JP2023561342A patent/JP2024513559A/ja active Pending
- 2022-04-07 BR BR112023020685A patent/BR112023020685A2/pt not_active Application Discontinuation
- 2022-04-07 US US18/554,248 patent/US20250074994A1/en active Pending
- 2022-04-07 KR KR1020237036653A patent/KR20230169182A/ko active Pending
- 2022-04-07 MX MX2023011978A patent/MX2023011978A/es unknown
- 2022-04-07 EP EP22719030.3A patent/EP4319883A1/en active Pending
- 2022-04-07 CA CA3214020A patent/CA3214020A1/en active Pending
- 2022-04-07 AU AU2022252985A patent/AU2022252985A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024513559A5 (https=) | ||
| JP2024509241A5 (https=) | ||
| JP2024508969A5 (https=) | ||
| US12285462B2 (en) | pH-triggered membrane peptide-mediated epitope tethering at cell surfaces | |
| JP4480580B2 (ja) | Ｗｔ１置換型ペプチド | |
| JP2023506765A5 (https=) | ||
| JP2023528207A5 (https=) | ||
| JP2010516290A5 (https=) | ||
| RU2017128465A (ru) | Неприродные семафорины класса 3 и их медицинское применение | |
| JP2023528204A5 (https=) | ||
| CN102869675A (zh) | 结合cxcr4受体的环状肽和相对医疗和诊断用途 | |
| JP2024508683A5 (https=) | ||
| JP2021514661A5 (https=) | ||
| JP2023522588A5 (https=) | ||
| JP2018512124A5 (https=) | ||
| JP2006506942A5 (https=) | ||
| JP2023554379A5 (https=) | ||
| JP2020509737A5 (https=) | ||
| CA2730686A1 (en) | Anti-amyloid immunogenic compositions, methods and uses | |
| JP2022535102A5 (https=) | ||
| JP2022507373A5 (https=) | ||
| US20140220074A1 (en) | Toll-Like Receptor 4 (Tlr-4) Agonist Peptides For Modulating Tlr-4 Mediated Immune Response | |
| JP2024525213A5 (https=) | ||
| CN115028738B (zh) | 一种Fc融合蛋白双重靶向降解剂及应用 | |
| JP2022528053A5 (https=) |